News Focus
News Focus
icon url

MackG

07/03/21 10:06 AM

#364261 RE: Justfactsmam #364258

JFM, spot on re. this quote from your post.

"With IPIX...THEY ARE NOT GOING TO ACQUIRE THE COMPANY with its EMPLOYEES... This will be an intellectual property sale or license agreement(s).

Advocating or suggesting "Partnership"...IMO is are not even close to reality. "Partnership" is not the fate of IPIX...sale or licensing of IP is. Suggesting "Partnership" is going down the wrong "Wabbit-hole"

I believe we will soon see the reality of this. The eventual revenue stream from licensing deals with Brilacidin alone has the potential to be massive. Great days lie ahead for IPIX longs imo.
icon url

loanranger

07/03/21 11:30 AM

#364266 RE: Justfactsmam #364258

"For better or worse IPIX designed and the FDA approved the trial to include patient status at day 60 for all participants."
That's not an INCORRECT STATEMENT at all. The original Brilacidin-Covid-19 Trial Protocol is in the Registry. The FDA obviously approved the trial as it appears in the Registry and I quoted the only sections that mentioned any 60 day elements. That's all the proof that anyone should need.
On the other hand, if you can prove this, go right ahead:
"It was imposed by the FDA across the board...AFTER Brilacidn trials were approved."